Medico Intercontinental MD, chairman and AGM

Medico Intercontinental board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

Managing directorSAMIR DILIPKUMAR SHAH
ChairpersonTANVI SAMIRBHAI SHAHRelated to the promoter
Company Secretary and Compliance OfficerPUNEETA SHARMA

6 directors3 independent1 executive2 non-executive

ANKUR AMIRAM DAVEIndependent · joined Mar 2019 · reappointed Mar 2024 · 90 months as independent · 1 listed board · 1 as independent · 3 committee seats, 3 as chair
SAMIR DILIPKUMAR SHAH · Managing directorExecutive · joined Aug 2018 · reappointed Aug 2023 · 1 listed board
TANVI SAMIRBHAI SHAH · ChairpersonNon-executive · joined Aug 2018 · reappointed Sep 2025 · 1 listed board · 3 committee seats
SWATI VIKRAMKUMAR SHAHNon-executive · joined May 2019 · reappointed Sep 2024 · 1 listed board
PARSHWA KAUSHAL SHAHIndependent · joined May 2024 · 28 months as independent · 1 listed board · 1 as independent
PRIYANK LALITBHAI SANCHETIIndependent · joined Nov 2022 · 46 months as independent · 1 listed board · 1 as independent · 3 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

Board
- 14 Aug 20266 of 6 present3 independent · 83 days in between
- 22 May 20266 of 6 present3 independent
Audit Committee
Chair ANKUR AMIRAM DAVE
PRIYANK LALITBHAI SANCHETI, TANVI SAMIRBHAI SHAH
- 14 Aug 20263 of 3 present2 independent · 83 days in between
- 22 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair ANKUR AMIRAM DAVE
PRIYANK LALITBHAI SANCHETI, TANVI SAMIRBHAI SHAH
- 22 May 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair ANKUR AMIRAM DAVE
PRIYANK LALITBHAI SANCHETI, TANVI SAMIRBHAI SHAH
No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

V GOSWAMI & COPeer-review certificate valid to Sep 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Medico Intercontinental AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Medico Intercontinental dividend history

Annual general meeting, 30 Sep 2026

4,040 shareholders on the register on 23 Sep 2026; present: 2 promoters and 23 others; votes counted by YASH MEHTA / YASH MEHTA & ASSOCIATES.The company's voting result (opens in a new tab)

1. To receive, consider and adopt the Audited Financial Statements (Standalone & Consolidated) for the financial year ended 31st March, 2026 together with the Reports of Board of Directors and Auditors thereon.MoreLess
Ordinary
99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 67.67% · promoters 100.00% · institutions 0.00% · other public 22.07%
2. To appoint Director in place of Mrs. Swati Jay Shah (DIN: 08420884), who retires by rotation and being eligible offers herself for reappointment.
Ordinary
99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 67.67% · promoters 100.00% · institutions 0.00% · other public 22.07%
3. APPROVAL FOR ENTERING INTO RELATED PARTY TRANSACTIONS WITH OXFORD PHARMA
OrdinaryPromoters have an interest in it
99.89% for0.11% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 9.16% · promoters 0.00% · institutions 0.00% · other public 22.07%
4. APPROVAL FOR ENTERING INTO RELATED PARTY TRANSACTIONS WITH LYF DISTRIBUTOR
OrdinaryPromoters have an interest in it
99.89% for0.11% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 9.16% · promoters 0.00% · institutions 0.00% · other public 22.07%
5. APPROVAL FOR ENTERING INTO RELATED PARTY TRANSACTIONS WITH MEDICO LAB
OrdinaryPromoters have an interest in it
99.89% for0.11% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 9.16% · promoters 0.00% · institutions 0.00% · other public 22.07%
6. APPROVAL FOR ENTERING INTO RELATED PARTY TRANSACTIONS WITH CALBORN LIFESCIENCE PRIVATE LIMITED
OrdinaryPromoters have an interest in it
99.89% for0.11% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 9.16% · promoters 0.00% · institutions 0.00% · other public 22.07%
7. APPROVAL FOR ENTERING INTO RELATED PARTY TRANSACTIONS WITH Mr. SAMIR D SHAH
OrdinaryPromoters have an interest in it
99.89% for0.11% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 9.16% · promoters 0.00% · institutions 0.00% · other public 22.07%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Dealings with its subsidiaries, promoters, directors and their firms, reported every half-year.Promoters and their stake

Half-year to Mar 2026: ₹40.8 Cr83 dealings, 3 loans and advances
Half-year to Sep 2025: ₹41.9 Cr75 dealings, 3 loans and advances
Half-year to Mar 2025: ₹21.3 Cr82 dealings, 1 loan or advance
Half-year to Sep 2024: ₹29.2 Cr77 dealings, 1 loan or advance
Half-year to Mar 2024: ₹10.4 Cr68 dealings
Half-year to Sep 2023: ₹26.9 Cr63 dealings

Between	Dealing
MEDICO INTERCONTINENTAL LIMITED and CALBORN LIFESCIENCE PRIVATE LIMITEDSUBSIDIARY	LoanLoan at 12.00%, Not Specified, unsecured, for its principal business activitiesLoan amount provided to Subsidiary has been utilized in principal business activities by the Subsidiary	15.00	10.82	13.17	23.88
MEDICO INTERCONTINENTAL LIMITED and CALBORN LIFESCIENCE PRIVATE LIMITEDSUBSIDIARY	Purchase of goods or services	28.00	5.65	0.31	3.33
CALBORN LIFESCIENCE PRIVATE LIMITED and PATEL SHAILESHBHAI SHIVABHAIDIRECTOR	Loan	4.00	4.21	0.00	4.24
MEDICO INTERCONTINENTAL LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Sale of goods or services	75.00	3.44	0.05	0.57
MEDICO INTERCONTINENTAL LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	75.00	2.04	0.00	0.00
CALBORN LIFESCIENCE PRIVATE LIMITED and PARESH J PATELDIRECTOR	Loan	4.00	1.98	0.74	2.78
MEDICO INTERCONTINENTAL LIMITED and MEDICO LABJOINT VENTURE	Sale of goods or services	100.00	1.63	0.88	0.47
MEDICO INTERCONTINENTAL LIMITED and EVAGRACE PHARMA PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Sale of goods or services	10.00	1.30	0.97	0.53
MEDICO INTERCONTINENTAL LIMITED and RITZ FORMULATIONS PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Sale of goods or services	20.00	1.25	0.22	0.35
AZILLIAN HEALTHCARE PRIVATE LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	10.00	1.21	0.33	0.12
MEDICO INTERCONTINENTAL LIMITED and CALBORN LIFESCIENCE PRIVATE LIMITEDSUBSIDIARY	Interest received	3.00	1.07	0.26	1.33
EVAGRACE PHARMA PRIVATE LIMITED and LYF PHARMA DISTRIBUTOREnterprises Significantly Influenced by Directors of Company	Sale of goods or services	2.50	0.82	1.25	1.12
MEDICO LAB and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	4.00	0.62	0.08	0.08
MEDICO INTERCONTINENTAL LIMITED and RITZ FORMULATIONS PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Purchase of goods or services	20.00	0.53	0.00	0.00
MEDICO INTERCONTINENTAL LIMITED and SUNGRACE PHARMA PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Sale of goods or services	20.00	0.45	0.46	0.44
RITZ FORMULATIONS PRIVATE LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	4.00	0.38	0.03	0.02
SUNGRACE PHARMA PRIVATE LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	4.00	0.37	0.04	0.04
MEDICO INTERCONTINENTAL LIMITED and AZILLIAN HEALTHCARE PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Sale of goods or services	20.00	0.32	0.35	0.30
MEDICO INTERCONTINENTAL LIMITED and SAMIR D SHAHKEY MANAGERIAL PERSONNEL - MD	Remuneration	30.00	0.30	0.00	0.00
MEDICO INTERCONTINENTAL LIMITED and MEDICO LABJOINT VENTURE	Any other transactionRETURN OF INVESTMENT	100.00	0.30	0.00	0.00
MEDICO INTERCONTINENTAL LIMITED and MEDICO LABJOINT VENTURE	Purchase of goods or services	100.00	0.24	0.00	0.00
MEDICO INTERCONTINENTAL LIMITED and EVAGRACE PHARMA PRIVATE LIMITEDWHOLLY OWNED SUBSIDIARY	Purchase of goods or services	10.00	0.23	0.00	0.00
EVAGRACE PHARMA PRIVATE LIMITED and OXFORD PHARMAEnterprises Significantly Influenced by Directors of Company	Purchase of goods or services	4.00	0.17	0.00	0.02
MEDICO INTERCONTINENTAL LIMITED and MEDICO LABJOINT VENTURE	Interest received	100.00	0.12	0.26	0.38
CALBORN LIFESCIENCE PRIVATE LIMITED and NILESH D PATELDIRECTOR	Remuneration	0.50	0.12	0.02	0.03

The 25 largest of 83 dealings in the half-year to Mar 2026, ₹ crore.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

Received
Resolved

Open at the quarter's end

None open at any quarter's end.

The board is made up as the listing rules require: Yes
The board has a regular chairperson: Yes
The company has a risk management committee: No
The chair is related to the managing director: Yes
The filing has a part on fines and penalties: No
The filing has a part on tax disputes: No
There was a cyber security incident in the quarter: No

The company's own answers in its filing.

Medico Intercontinental board of directors

Committees and meetings

Board

Audit Committee

Nomination and remuneration committee

Stakeholders Relationship Committee